IPD Stock Overview
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ImpediMed Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.086 |
| 52 Week High | AU$0.24 |
| 52 Week Low | AU$0.076 |
| Beta | 2.93 |
| 1 Month Change | 0% |
| 3 Month Change | -33.85% |
| 1 Year Change | -53.51% |
| 3 Year Change | -25.22% |
| 5 Year Change | -67.55% |
| Change since IPO | -89.88% |
Recent News & Updates
Recent updates
ImpediMed (ASX:IPD) Is In A Good Position To Deliver On Growth Plans
Mar 05
Companies Like ImpediMed (ASX:IPD) Are In A Position To Invest In Growth
Nov 23Is ImpediMed (ASX:IPD) In A Good Position To Deliver On Growth Plans?
Jul 11We Think ImpediMed (ASX:IPD) Needs To Drive Business Growth Carefully
Mar 27Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation
Sep 28We're Not Worried About ImpediMed's (ASX:IPD) Cash Burn
Jun 10A Look At The Fair Value Of ImpediMed Limited (ASX:IPD)
Feb 01We Think ImpediMed (ASX:IPD) Can Afford To Drive Business Growth
Aug 25Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation
Apr 06Analysts Expect Breakeven For ImpediMed Limited (ASX:IPD) Before Long
Feb 12
ImpediMed's (ASX:IPD) Stock Price Has Reduced 88% In The Past Five Years
Jan 08How Does ImpediMed's (ASX:IPD) CEO Salary Compare to Peers?
Nov 25Shareholder Returns
| IPD | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -7.5% | 0.3% | 0.4% |
| 1Y | -53.5% | 13.9% | 6.0% |
Return vs Industry: IPD underperformed the Australian Medical Equipment industry which returned 13.9% over the past year.
Return vs Market: IPD underperformed the Australian Market which returned 6% over the past year.
Price Volatility
| IPD volatility | |
|---|---|
| IPD Average Weekly Movement | 12.1% |
| Medical Equipment Industry Average Movement | 10.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: IPD's share price has been volatile over the past 3 months.
Volatility Over Time: IPD's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 76 | Parmjot Bains | www.impedimed.com |
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics.
ImpediMed Limited Fundamentals Summary
| IPD fundamental statistics | |
|---|---|
| Market cap | AU$173.99m |
| Earnings (TTM) | -AU$19.50m |
| Revenue (TTM) | AU$10.47m |
16.6x
P/S Ratio-8.9x
P/E RatioIs IPD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IPD income statement (TTM) | |
|---|---|
| Revenue | AU$10.47m |
| Cost of Revenue | AU$1.37m |
| Gross Profit | AU$9.11m |
| Other Expenses | AU$28.60m |
| Earnings | -AU$19.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | -0.0096 |
| Gross Margin | 86.95% |
| Net Profit Margin | -186.16% |
| Debt/Equity Ratio | 0% |
How did IPD perform over the long term?
See historical performance and comparison